Showing results (41-50 of 157) with videos related to
Sort By:
Pageof 16
Antimicrobial Agents and Chemotherapy|April 1, 1987
Inhibition of R-plasmid transfer in Escherichia coli by 4-quinolonesJ Weisser, B WiedemannThorax|July 4, 2002
Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) projectG Steinkamp, B WiedemannThe Journal of Antimicrobial Chemotherapy|March 4, 1998
Antibacterial activity of grepafloxacinB Wiedemann, P HeisigAntimicrobial Agents and Chemotherapy|March 18, 2000
Pronounced postantibiotic effect of quinupristin-dalfopristin in static cultures of Staphylococcus aureus: an effect not seen with other antibioticsE Pfeil, B WiedemannAntimicrobial Agents and Chemotherapy|June 1, 1990
Antibacterial activity of lomefloxacin in a pharmacokinetic in vitro modelC Rustige, B WiedemannPadiatrie Und Grenzgebiete|January 1, 1990
[Risk factors of fitness for child day care in 2 independent studies]I Passauer, B WiedemannKlinische Monatsblatter Fur Augenheilkunde|October 1, 1994
[The COMOD system. A preservative-free multidose container for eyedrops]C Teping, B WiedemannZentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|July 1, 1996
The role of N-actylglucosaminyl-1,6 anhydro N-acetylmuramyl-L-alanyl-D-glutamyl-meso-diaminopimelic acid-D-alanine for the induction of beta-lactamase in Enterobacter cloacaeH Dietz, B WiedemannThe Journal of Antimicrobial Chemotherapy|July 1, 1990
Antibacterial activity of cefpodoxime proxetil in a pharmacokinetic in-vitro modelB Wiedemann, A JansenAntimicrobial Agents and Chemotherapy|May 1, 1995
Mathematical corrections for bacterial loss in pharmacodynamic in vitro dilution modelsS Keil, B WiedemannPageof 16